Rheumatology NewsPsA disease activity and treatment success definedAugust 13, 2015Psoriatic ArthritisSpondyloarthropathies
Rheumatology NewsApremilast response durable at 52 weeksAugust 13, 2015Psoriatic ArthritisSpondyloarthropathies
Rheumatology NewsGRAPPA initiatives continue to chart the way for psoriasis, psoriatic arthritisJuly 22, 2015Psoriatic ArthritisSpondyloarthropathies
Rheumatology NewsSecukinumab proves successful against psoriatic arthritis in FUTURE 2 trialJuly 17, 2015Psoriatic ArthritisSpondyloarthropathies
Rheumatology NewsWCD: Touch avoidance is a new dimension of psoriatic impairmentJuly 13, 2015Psoriatic ArthritisSpondyloarthropathies
Rheumatology NewsGuselkumab prevails in phase II psoriasis trialJuly 8, 2015SpondyloarthropathiesPsoriatic Arthritis
Rheumatology NewsEULAR’s psoriatic arthritis recommendations gain new drugsJuly 1, 2015Psoriatic ArthritisSpondyloarthropathies
Rheumatology NewsEULAR: Panel targets six rheumatic disease comorbiditiesJuly 1, 2015Rheumatoid ArthritisPsoriatic ArthritisGoutLupus & Connective Tissue DiseasesSpondyloarthropathies
Rheumatology NewsWCD: Secukinumab shows effectiveness for nail, palmoplantar psoriasisJune 28, 2015SpondyloarthropathiesPsoriatic Arthritis
Rheumatology NewsWCD: IL-23p19 inhibitors yield ‘promising’ psoriasis resultsJune 28, 2015Psoriatic ArthritisSpondyloarthropathies
Rheumatology NewsWCD: Ixekizumab beats etanercept for psoriatic itchJune 27, 2015SpondyloarthropathiesPsoriatic Arthritis
Rheumatology NewsVIDEO: Could a deep Koebner phenomenon trigger psoriatic arthritis?June 27, 2015Psoriatic ArthritisSpondyloarthropathies
Rheumatology NewsAmgen’s termination of brodalumab stuns psoriasis worldJune 25, 2015Psoriatic ArthritisSpondyloarthropathies
Rheumatology NewsLasting ustekinumab benefits seen in psoriatic arthritisJune 22, 2015Psoriatic ArthritisSpondyloarthropathies
Rheumatology NewsLarge-scale psoriasis study links trauma to arthritisJune 16, 2015Psoriatic ArthritisSpondyloarthropathies
